Overview

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers

Status:
Completed
Trial end date:
2020-10-07
Target enrollment:
Participant gender:
Summary
This study is designed as a randomized, open-label, single-dose, 6x3 crossover study.
Phase:
Early Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd